S&P 500   4,364.33 (-1.77%)
DOW   34,394.63 (-1.36%)
QQQ   361.00 (-2.52%)
AAPL   142.65 (-1.87%)
MSFT   285.59 (-2.92%)
FB   341.12 (-3.52%)
GOOGL   2,724.52 (-3.44%)
TSLA   779.53 (-1.49%)
AMZN   3,309.51 (-2.83%)
NVDA   208.14 (-3.91%)
BABA   149.95 (-0.15%)
NIO   35.30 (-4.00%)
CGC   14.26 (-3.06%)
GE   104.99 (-0.34%)
MU   73.51 (-2.22%)
AMD   103.00 (-4.77%)
T   27.27 (-0.47%)
F   14.32 (+1.13%)
ACB   6.83 (+6.89%)
DIS   174.26 (-2.24%)
PFE   42.92 (-1.49%)
BA   219.09 (-2.26%)
AMC   37.55 (-4.45%)
S&P 500   4,364.33 (-1.77%)
DOW   34,394.63 (-1.36%)
QQQ   361.00 (-2.52%)
AAPL   142.65 (-1.87%)
MSFT   285.59 (-2.92%)
FB   341.12 (-3.52%)
GOOGL   2,724.52 (-3.44%)
TSLA   779.53 (-1.49%)
AMZN   3,309.51 (-2.83%)
NVDA   208.14 (-3.91%)
BABA   149.95 (-0.15%)
NIO   35.30 (-4.00%)
CGC   14.26 (-3.06%)
GE   104.99 (-0.34%)
MU   73.51 (-2.22%)
AMD   103.00 (-4.77%)
T   27.27 (-0.47%)
F   14.32 (+1.13%)
ACB   6.83 (+6.89%)
DIS   174.26 (-2.24%)
PFE   42.92 (-1.49%)
BA   219.09 (-2.26%)
AMC   37.55 (-4.45%)
S&P 500   4,364.33 (-1.77%)
DOW   34,394.63 (-1.36%)
QQQ   361.00 (-2.52%)
AAPL   142.65 (-1.87%)
MSFT   285.59 (-2.92%)
FB   341.12 (-3.52%)
GOOGL   2,724.52 (-3.44%)
TSLA   779.53 (-1.49%)
AMZN   3,309.51 (-2.83%)
NVDA   208.14 (-3.91%)
BABA   149.95 (-0.15%)
NIO   35.30 (-4.00%)
CGC   14.26 (-3.06%)
GE   104.99 (-0.34%)
MU   73.51 (-2.22%)
AMD   103.00 (-4.77%)
T   27.27 (-0.47%)
F   14.32 (+1.13%)
ACB   6.83 (+6.89%)
DIS   174.26 (-2.24%)
PFE   42.92 (-1.49%)
BA   219.09 (-2.26%)
AMC   37.55 (-4.45%)
S&P 500   4,364.33 (-1.77%)
DOW   34,394.63 (-1.36%)
QQQ   361.00 (-2.52%)
AAPL   142.65 (-1.87%)
MSFT   285.59 (-2.92%)
FB   341.12 (-3.52%)
GOOGL   2,724.52 (-3.44%)
TSLA   779.53 (-1.49%)
AMZN   3,309.51 (-2.83%)
NVDA   208.14 (-3.91%)
BABA   149.95 (-0.15%)
NIO   35.30 (-4.00%)
CGC   14.26 (-3.06%)
GE   104.99 (-0.34%)
MU   73.51 (-2.22%)
AMD   103.00 (-4.77%)
T   27.27 (-0.47%)
F   14.32 (+1.13%)
ACB   6.83 (+6.89%)
DIS   174.26 (-2.24%)
PFE   42.92 (-1.49%)
BA   219.09 (-2.26%)
AMC   37.55 (-4.45%)
NASDAQ:FTRP

Field Trip Health Stock Forecast, Price & News

$4.52
-0.12 (-2.59 %)
(As of 09/28/2021 11:46 AM ET)
Add
Compare
Today's Range
$4.52
$4.64
50-Day Range N/A
52-Week Range
$1.87
$7.71
Volume400 shs
Average Volume72,082 shs
Market Capitalization$260.63 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive FTRP News and Ratings via Email

Sign-up to receive the latest news and ratings for Field Trip Health and its competitors with MarketBeat's FREE daily newsletter.


Field Trip Health logo

About Field Trip Health

Field Trip Health Ltd. is involved in the development and delivery of psychedelic therapies. Field Trip Health Ltd. is based in TORONTO.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FTRP
CIK
N/A
Phone
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$260.63 million
Next Earnings Date
11/15/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.37 out of 5 stars

Medical Sector

1092nd out of 1,353 stocks

Analyst Opinion: 3.5Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Field Trip Health (NASDAQ:FTRP) Frequently Asked Questions

Is Field Trip Health a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Field Trip Health in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Field Trip Health stock.
View analyst ratings for Field Trip Health
or view top-rated stocks.

What stocks does MarketBeat like better than Field Trip Health?

Wall Street analysts have given Field Trip Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Field Trip Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Field Trip Health?

Field Trip Health saw a increase in short interest in August. As of August 31st, there was short interest totaling 18,700 shares, an increase of 163.4% from the August 15th total of 7,100 shares. Based on an average daily volume of 90,300 shares, the short-interest ratio is presently 0.2 days. Approximately 0.1% of the shares of the stock are sold short.
View Field Trip Health's Short Interest
.

When is Field Trip Health's next earnings date?

Field Trip Health is scheduled to release its next quarterly earnings announcement on Monday, November 15th 2021.
View our earnings forecast for Field Trip Health
.

What price target have analysts set for FTRP?

1 Wall Street analysts have issued 1 year price targets for Field Trip Health's shares. Their forecasts range from $20.00 to $20.00. On average, they anticipate Field Trip Health's stock price to reach $20.00 in the next twelve months. This suggests a possible upside of 331.0% from the stock's current price.
View analysts' price targets for Field Trip Health
or view top-rated stocks among Wall Street analysts.

What is Field Trip Health's stock symbol?

Field Trip Health trades on the NASDAQ under the ticker symbol "FTRP."

How do I buy shares of Field Trip Health?

Shares of FTRP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Field Trip Health's stock price today?

One share of FTRP stock can currently be purchased for approximately $4.64.

How much money does Field Trip Health make?

Field Trip Health has a market capitalization of $267.55 million.

What is Field Trip Health's official website?

The official website for Field Trip Health is www.fieldtriphealth.com.


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.